Related Experiment Videos
Long-term oxygen therapy with concentrators and liquid oxygen
1Department of Pneumology, University Hospital Gasthuisberg, Catholic University Leuven.
Acta Clinica Belgica
|January 1, 1995
Summary
Long-term oxygen therapy (LTOT) in Belgium, using concentrators or liquid oxygen, was studied in 83 patients. Improved oxygen levels in COPD patients receiving LTOT correlated with better survival rates.
Area of Science:
- Pulmonary Medicine
- Respiratory Therapy
Background:
- The National Institute for Insurance of Disease and Disablement (RIZIV/INAMI) in Belgium has reimbursed long-term oxygen therapy (LTOT) since 1984 for specific patient groups.
- LTOT is provided via oxygen concentrators and liquid oxygen systems.
Purpose of the Study:
- To evaluate the outcomes and survival rates of patients receiving LTOT.
- To assess the impact of LTOT on patients with Chronic Obstructive Pulmonary Disease (COPD), lung fibrosis, and other respiratory conditions.
Main Methods:
- Retrospective analysis of 83 patients prescribed LTOT between 1984 and 1992.
- Data collected included patient demographics, disease type, therapy type (concentrator or liquid oxygen), and physiological parameters (PaO2, PaCO2).
- Survival rates and factors influencing survival were analyzed, particularly in COPD patients.
Main Results:
- Of 83 patients, 49 had COPD, 12 lung fibrosis, and 22 miscellaneous diseases.
- Two-year survival was 75% overall and 60% for COPD patients.
- In COPD patients, improved PaO2 after 1 year of LTOT was significantly related to survival (p < 0.05).
Conclusions:
- LTOT is a viable treatment for specific respiratory conditions, with significant survival benefits observed.
- Monitoring oxygenation levels and patient response is crucial for optimizing LTOT effectiveness and patient outcomes, especially in COPD.